PRA's Central Review Services team, unique in the CRO industry, offers lupus-specific expertise in efficacy endpoint data correlation, standardized central medical review and grading, and investigator site training.
Explore related content and topics
White Paper
Strategies for Accelerating Rare Disease Clinical Development
Rare disease trials differ from those in most other therapeutic areas because the indications are more complex and involve smaller patient…
View Resource
Publication
Successful Adaptation to the Evolution of Complex Dose Escalation Within a Large Master Protocol Basket Design Across IO Co-Therapies
A case study describing a Phase I dose escalation and cohort expansion study of an immune checkpoint inhibitor in patients with advanced solid…
View Resource
Blog
New Ways to Think Strategically About Clinical Trial Transparency
Clinical teams face increasing pressure to adapt to recent advances within trial transparency. Clinical trial transparency now incorporates sharing…
Read Story
View all related content and resources for Medical Affairs
Explore Insights